CHOLESTECH CORPORATION [Rocket]

In millions, except per share items	Mar-30-07	Mar-31-06	Mar-25-05	Mar-26-04	Mar-28-03	Mar-29-02	Mar-30-01	Mar-31-00
Revenues	69.5	64.1	52.9	52.4	48.5	41.7	32.5	27.5
Revenue growth	8.5%	21.2%	1.0%	7.9%	16.3%	28.5%	17.9%
Cost of goods sold	23.0	23.9	21.4	23.2	20.4	17.0	14.1	11.2
Gross profit	46.5	40.2	31.5	29.2	28.1	24.7	18.4	16.3
Gross margin	66.9%	62.7%	59.5%	55.7%	57.9%	59.2%	56.7%	59.3%
Sales and marketing	14.8	13.0	11.5	12.7	11.7	9.2	8.3	7.0
Research and development	6.3	7.6	4.3	3.2	2.7	2.2	2.2	3.0
General and administrative	13.7	11.2	9.9	8.2	7.0	6.4	4.3	3.5
EBITA	11.7	8.4	5.9	-2.8	6.3	6.7	2.3	2.6
EBITA margin	16.8%	13.1%	11.1%	-5.4%	13.1%	16.0%	7.2%	9.3%
Amortization of intangibles								0.1
EBIT	11.7	8.4	5.9	-2.8	6.3	6.7	2.3	2.5
EBIT margin	16.8%	13.1%	11.1%	-5.4%	13.1%	16.0%	7.2%	8.9%
Pre-tax income	13.9	9.3	6.1	-2.5	6.8	7.1	3.0	3.3
Income taxes	4.5	3.7	2.0	-11.2	-3.9	0.3	0.2	0.1
Tax rate	32.1%	39.4%	32.2%	452.2%		4.0%	7.5%	4.0%
Earnings from continuing ops	9.4	5.6	4.1	8.7	10.7	6.9	2.8	3.1
Earnings from discontinued ops					-1.4	-1.3	-2.6
Net income	9.4	5.6	4.1	8.7	4.9	5.6	0.2	3.1
Net margin	13.5%	8.8%	7.8%	16.6%	10.1%	13.3%	0.5%	11.4%

Diluted EPS	$0.61	$0.38	$0.29	$0.61	$0.76	$499.05	$0.22	$262.75
Shares outstanding (diluted)	15.5	15.0	14.5	14.2	14.1	0.0	12.4	0.0

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.